Skip to main content

Kezar Life Sciences, Inc.

KZRDelisted May 11, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001645666

Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.

13F holders, Q1 2025

Institutional positions in Kezar Life Sciences, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
41
−1 vs. Q4 2024
Shares held
4.33M
+128.2K (+3.1%) vs. Q4 2024
Total value
$21.1M
−$7.10M (−25.2%) vs. Q4 2024
New holders
5
7 more added
Sold out
6
14 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 41 institutions
Q1 2021: 83 institutionsQ2 2021: 75 institutionsQ3 2021: 77 institutionsQ4 2021: 107 institutionsQ1 2022: 123 institutionsQ2 2022: 127 institutionsQ3 2022: 132 institutionsQ4 2022: 123 institutionsQ1 2023: 137 institutionsQ2 2023: 104 institutionsQ3 2023: 82 institutionsQ4 2023: 81 institutionsQ1 2024: 85 institutionsQ2 2024: 81 institutionsQ3 2024: 60 institutionsQ4 2024: 43 institutionsQ1 2025: 41 institutionsQ2 2025: 40 institutionsQ3 2025: 39 institutionsQ4 2025: 43 institutionsQ1 2026: 43 institutionsQ2 2026: 0 institutions
Value heldQ1 2025: $21.1M
Q1 2021: $158.0MQ2 2021: $150.1MQ3 2021: $242.7MQ4 2021: $674.1MQ1 2022: $734.1MQ2 2022: $454.0MQ3 2022: $495.5MQ4 2022: $404.2MQ1 2023: $188.1MQ2 2023: $139.4MQ3 2023: $66.0MQ4 2023: $46.8MQ1 2024: $40.3MQ2 2024: $23.6MQ3 2024: $31.6MQ4 2024: $28.2MQ1 2025: $21.1MQ2 2025: $20.5MQ3 2025: $16.5MQ4 2025: $28.1MQ1 2026: $32.8MQ2 2026: $0
Institutions holding KZR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 202643$32.8M
Q4 202543$28.1M
Q3 202539$16.5M
Q2 202540$20.5M
Q1 202541$21.1M
Q4 202443$28.2M
Q3 202460$31.6M
Q2 202481$23.6M
Q1 202485$40.3M
Q4 202381$46.8M
Q3 202382$66.0M
Q2 2023104$139.4M
Q1 2023137$188.1M
Q4 2022123$404.2M
Q3 2022132$495.5M
Q2 2022127$454.0M
Q1 2022123$734.1M
Q4 2021107$674.1M
Q3 202177$242.7M
Q2 202175$150.1M
Q1 202183$158.0M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q4 2024.

Institutions holding KZR in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Tang Capital Management LLC720,000$3.51M0.19%00.0%Unchanged
Suvretta Capital Management, LLC716,759$3.50M0.14%00.0%Unchanged
Avidity Partners Management LP502,600$2.45M0.51%00.0%Unchanged
BML Capital Management, LLC408,138$1.99M1.61%+359,470+738.6%Added
Vanguard Group Inc276,228$1.35M0.00%+2,117+0.8%Added
OrbiMed Advisors LLC192,700$940.4K0.02%00.0%Unchanged
ADAR1 Capital Management, LLC147,404$719.3K0.14%00.0%Unchanged
Acadian Asset Management LLC133,525$650.0K0.00%−12,141−8.3%Reduced
Peapod Lane Capital LLC124,427$607.2K0.68%+433+0.3%Added
Sphera Funds Management Ltd.108,473$529.3K0.13%00.0%Unchanged
Ikarian Capital, LLC106,901$521.7K0.17%00.0%Unchanged
Stonepine Capital Management, LLC100,000$488.0K0.57%−10,000−9.1%Reduced
Renaissance Technologies LLC85,584$417.6K0.00%−2,101−2.4%Reduced
Qiming U.S. Ventures Management, LLC82,871$404.4K1.75%00.0%Unchanged
BlackRock, Inc.82,614$403.2K0.00%−241−0.3%Reduced
Geode Capital Management, LLC67,564$329.8K0.00%+994+1.5%Added
Shay Capital LLC67,511$329.5K0.10%+8,353+14.1%Added
Two Sigma Advisers, LP64,509$314.8K0.00%−35,632−35.6%Reduced
Bridgeway Capital Management, LLC41,000$200.1K0.01%+41,000New
Dimensional Fund Advisors LP32,310$157.7K0.00%00.0%Unchanged
Two Sigma Investments, LP31,870$155.5K0.00%−30,113−48.6%Reduced
Millennium Management LLC31,380$153.1K0.00%−11,957−27.6%Reduced
RBF Capital, LLC28,253$137.9K0.01%00.0%Unchanged
Goldman Sachs Group Inc28,178$137.5K0.00%−24,094−46.1%Reduced
Woodline Partners LP25,555$124.7K0.00%+25,555New
State Street Corp21,093$102.9K0.00%00.0%Unchanged
Boothbay Fund Management, LLC20,900$102.0K0.00%00.0%Unchanged
Squarepoint Ops LLC20,299$99.1K0.00%+20,299New
Clear Harbor Asset Management, LLC15,805$77.1K0.01%+15,805New
FMR LLC14,305$69.8K0.00%+5,904+70.3%Added
Northern Trust Corp13,940$68.0K0.00%00.0%Unchanged
Morgan Stanley7,211$35.2K0.00%−13,398−65.0%Reduced
Wells Fargo & Company5,703$27.8K0.00%−474−7.7%Reduced
UBS Group AG2,040$9.96K0.00%−12,800−86.3%Reduced
Bank of America Corp172$8390.00%+2+1.2%Added
JPMorgan Chase & Co166$8100.00%−11,718−98.6%Reduced
BNP Paribas Arbitrage, SA96$4680.00%−13−11.9%Reduced
CIBC Private Wealth Group, LLC100$4020.00%+100New
Citigroup Inc51$2490.00%00.0%Unchanged
Advisor Group Holdings, Inc.4$200.00%−465−99.1%Reduced
Barclays PLC1$50.00%00.0%Unchanged
Affinity Asset Advisors, LLC0$00.00%−142,316−100.0%Sold out
Marquette Asset Management, LLC0$00.00%−17,805−100.0%Sold out
Citadel Advisors LLC0$00.00%−16,870−100.0%Sold out
Amundi0$00.00%−8,224−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−1,036−100.0%Sold out
Simplex Trading, LLC0$00.00%−400−100.0%Sold out
Global Retirement Partners, LLC––––Not filed